Multiple Myelomas News

Orlowski on the Role of Maintenance Therapy in Multiple Myeloma - Targeted Oncology



Targeted Oncology
 
Orlowski on the Role of Maintenance Therapy in Multiple Myeloma 
Targeted Oncology
Robert Z. Orlowski, MD, PhD, recently discussed 2 cases of patients with multiple myeloma, and the treatment considerations and decisions he would make when treating these patients. Orlowski, chairman, ad interim, director of myeloma, and professor of ...

 


Dr. Kumar on Properly Managing Patients With Multiple Myeloma - OncLive



Dr. Kumar on Properly Managing Patients With Multiple Myeloma 
OncLive
Shaji K. Kumar, MD, professor of medicine, Mayo Clinic, discusses properly managing patients with multiple myeloma. If patients with newly-diagnosed disease are properly managed, then there is a possibility for a longer duration of remission. Kumar ...

 


Gene Signature Helped Predict Poor Response to IMiDs in Multiple Myeloma - Cancer Network



Gene Signature Helped Predict Poor Response to IMiDs in Multiple Myeloma 
Cancer Network
Researchers have developed a model that has prognostic value in predicting favorable or unfavorable responses to immunomodulatory derivative (IMiDs) in patients with multiple myeloma, according to the results of a study published in the September issue ...

 


Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2017 - Markets Insider



Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2017 
Markets Insider
DARZALEX® (daratumumab) injection for intravenous infusion is indicated in the United States in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of patients with multiple myeloma who have received ...

 


Expert Talks Treating Newly Diagnosed Patients With Myeloma - Curetoday.com



Curetoday.com
 
Expert Talks Treating Newly Diagnosed Patients With Myeloma 
Curetoday.com
Kumar, professor of Medicine, Mayo Clinic, discussed proper diagnosis, risk stratification and personalized medicine for patients with multiple myeloma during an interview with CURE the National Comprehensive Cancer Network (NCCN) 12th Annual ...

 


Multiple myeloma trial opened to patients - The San Diego Union-Tribune



The San Diego Union-Tribune
 
Multiple myeloma trial opened to patients 
The San Diego Union-Tribune
San Diego's Poseida Therapeutics has begun enrolling patients in a clinical trial of a therapy for those with multiple myeloma. While the trial is mainly concerned with safety, it's also designed to look for signs of efficacy, Eric Ostertag, M.D., CEO ...

 


Second Interim Analysis Suggests Carfilzomib Improves Survival in Multiple Myeloma - AJMC.com Managed Markets Network



Second Interim Analysis Suggests Carfilzomib Improves Survival in Multiple Myeloma 
AJMC.com Managed Markets Network
Following the phase 3 ENDEAVOR trial that compared 2 proteasome inhibitors?carfilzomib and bortezomib?in relapsed or refractory multiple myeloma patients, researchers conducted a second interim analysis to compare the overall survival between the 2 ...

 


Individualized Treatment Needed for Relapsed, Refractory Multiple Myeloma - Curetoday.com



Curetoday.com
 
Individualized Treatment Needed for Relapsed, Refractory Multiple Myeloma 
Curetoday.com
Patients with relapsed/refractory multiple myeloma should be given individualized treatment approaches guided by the biology of their disease, frailty of the patient and other comorbidities, said Natalie S. Callander, M.D., who presented on the topic ...

 


Treatment for Relapsed/Refractory Multiple Myeloma Based on Biology, Time to Relapse - OncLive



OncLive
 
Treatment for Relapsed/Refractory Multiple Myeloma Based on Biology, Time to Relapse 
OncLive
The treatment approach for patients with relapsed/refractory (R/R) multiple myeloma (MM) should be tailored based on biology of the disease, frailty of the patient, and comorbidities, said Natalie S. Callander, MD, in a presentation at the NCCN 12th ...

 


Natural Killer immune cells may help fight cancer - First Coast News



First Coast News
 
Natural Killer immune cells may help fight cancer 
First Coast News
The study of Natural Killer (NK) cells are being studied at the University of Nebraska Medical Center focuses to see if they can treat Multiple Myeloma, an incurable form of cancer. It's a cancer that forms in the blood cells and found in the bone marrow.